Scarica l'app Stockscreener
6.60
3.65%
-0.25
Dopo l'orario di chiusura:
6.48
-0.12
-1.82%
Lyra Therapeutics Inc Azioni (LYRA) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
0.00%
0.183
|
0.183 | 0.209 | 0.195 | 0.598 |
Operating Expenses
|
0.17%
9.009
|
9.024 | 11.62 | 12.64 | 49.57 |
| Benefits Costs and Expenses |
12.70%
7.618
|
8.726 | 11.18 | 12.06 | 48.72 |
| Costs And Expenses |
12.70%
7.618
|
8.726 | 11.18 | 12.06 | 48.72 |
| Operating Income/Loss |
0.17%
-8.826
|
-8.841 | -11.41 | -12.44 | -48.97 |
| Nonoperating Income/Loss |
366.78%
1.391
|
0.298 | 0.435 | 0.576 | 0.855 |
| Income/Loss From Continuing Operations Before Tax |
12.97%
-7.435
|
-8.543 | -10.97 | -11.87 | -48.12 |
| Income Tax Expense/Benefit |
50.00%
0.002
|
0.004 | 0.006 | 0.007 | 0.012 |
| Income/Loss From Continuing Operations After Tax |
12.99%
-7.437
|
-8.547 | -10.98 | -11.87 | -48.13 |
|
Net Income/Loss
|
12.99%
-7.437
|
-8.547 | -10.98 | -11.87 | -48.13 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
97.95%
1.3486
|
65.76 | 0.1326 | 65.46 | 65.46 |
| Diluted Average Shares |
97.95%
1.3486
|
65.76 | 0.1326 | 65.46 | 65.46 |
| Basic Earnings Per Share |
4,138%
-5.51
|
-0.13 | -0.16 | -0.18 | -0.74 |
| Diluted Earnings Per Share |
4,138%
-5.51
|
-0.13 | -0.16 | -0.18 | -0.74 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.75%
0.00%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):